B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CYP2C19

MOLECULAR TARGET

cytochrome P450 family 2 subfamily C member 19

UniProt: P33261NCBI Gene: 1557334 compounds

CYP2C19 (cytochrome P450 family 2 subfamily C member 19) is targeted by 334 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CYP2C19

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Disulfiram2.4811
2Clotrimazole2.208
3Isoniazid Antibacterial agent used primarily as2.208
4Levonorgestrel2.208
5Norgestrel2.208
6Apigenin 5,7,4'-trihydroxy-flavone,2.087
7Quercetin2.087
8Ethinyl Estradiol2.087
9Finasteride2.087
10Flutamide2.087
11Methoxsalen2.087
12Rotenone2.087
13Androstenedione1.956
14Carbaryl1.956
15Chlorhexidine1.956
16Cimetidine1.956
17Corticosterone1.956
18Ethoxyquin Antioxidant; also1.956
19Fulvestrant1.956
20Loratadine1.956
21Vitamin K 31.956
22Piribedil1.956
23Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables.1.956
24Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against1.956
25Tolazamide1.956
26Genistein1.795
27Progesterone1.795
28Colchicine1.795
29Fenofibrate1.795
30Lovastatin1.795
31Mestranol1.795
32Nisoldipine1.795
33Phenylbutazone1.795
34Phenytoin1.795
35Sulindac1.795
36Zearalenone (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradec in-1,7(8H)-dione.1.795
37chrysin1.614
38Pueraria1.614
39Dehydroepiandrosterone1.614
40Fluoxetine1.614
41Kaempferols1.614
42Melatonin1.614
43Methylene Blue1.614
44propyl gallate1.614
45Vitamin1.614
4617-alpha-Hydroxyprogesterone1.614
4717 alpha-Hydroxyprogesterone Caproate Hydroxyprogesterone derivative that acts as1.614
48Anabasine1.614
49Anastrozole1.614
50Carboxin1.614

Showing top 50 of 334 compounds. Use the BiohacksAI search to explore all CYP2C19 modulators.

About CYP2C19 as a Drug Target

CYP2C19 (cytochrome P450 family 2 subfamily C member 19) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 334 compounds with documented CYP2C19 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CYP2C19 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.